June 7 (Reuters) – A U.S. advisory panel recommended
approving Teva Pharmaceutical Industries Ltd’s
long-acting opioid painkiller, Vantrela ER, saying data
showed it has some abuse-resistant…
The post UPDATE 3-FDA panel backs Teva’s abuse-resistant opioid painkiller appeared first on NASDAQ.